Literature DB >> 20434484

Improved mycobacterial tetracycline inducible vectors.

Kerstin J Williams1, Graham Joyce, Brian D Robertson.   

Abstract

We have previously reported on the development and assessment of the tetracycline inducible vector pMIND (Blokpoel et al., 2005). Here we report the development of improved pMIND vectors that exhibit both reduced basal transcription in the absence of inducer and increased fold induction in the presence of inducer. An amino acid change in the repressor protein, TetR(Z), produced a 6-fold reduction in basal transcription compared to the original pMIND-Lx and a 100-fold induction of LuxAB in the presence of tetracycline. An integration version of the improved vector (pMEND-Lx) was constructed which resulted in a 9-fold reduction in basal transcription compared to pMIND-Lx and a 17-fold induction of LuxAB in the presence of tetracycline. Further improvements were obtained by cloning the pMEND TetRO promoter into an alternative vector backbone. The resulting vector, pKW08-Lx, exhibited a 70-fold reduction in background compared to pMIND-Lx and a 230-fold induction of LuxAB in the presence of tetracycline. An integration version of pKW08-Lx was constructed and the basal transcription for this vector was zero; an 11-fold induction of LuxAB was observed in the presence of tetracycline. The construction of these improved mycobacterial vectors will prove extremely useful for genetic studies. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20434484      PMCID: PMC3495547          DOI: 10.1016/j.plasmid.2010.04.003

Source DB:  PubMed          Journal:  Plasmid        ISSN: 0147-619X            Impact factor:   3.466


  14 in total

1.  Tetracycline-inducible gene expression in mycobacteria within an animal host using modified Streptomyces tcp830 regulatory elements.

Authors:  S Moises Hernandez-Abanto; Samuel C Woolwine; Sanjay K Jain; W R Bishai
Journal:  Arch Microbiol       Date:  2006-08-30       Impact factor: 2.552

2.  Use of a tetracycline-inducible system for conditional expression in Mycobacterium tuberculosis and Mycobacterium smegmatis.

Authors:  Paul Carroll; D G Niranjala Muttucumaru; Tanya Parish
Journal:  Appl Environ Microbiol       Date:  2005-06       Impact factor: 4.792

3.  TetZ, a new tetracycline resistance determinant discovered in gram-positive bacteria, shows high homology to gram-negative regulated efflux systems.

Authors:  A Tauch; A Pühler; J Kalinowski; G Thierbach
Journal:  Plasmid       Date:  2000-11       Impact factor: 3.466

4.  Genetic requirements for mycobacterial survival during infection.

Authors:  Christopher M Sassetti; Eric J Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-20       Impact factor: 11.205

5.  Silencing Mycobacterium smegmatis by using tetracycline repressors.

Authors:  Xinzheng V Guo; Mercedes Monteleone; Marcus Klotzsche; Annette Kamionka; Wolfgang Hillen; Miriam Braunstein; Sabine Ehrt; Dirk Schnappinger
Journal:  J Bacteriol       Date:  2007-05-04       Impact factor: 3.490

6.  Contacts between Tet repressor and tet operator revealed by new recognition specificities of single amino acid replacement mutants.

Authors:  R Baumeister; V Helbl; W Hillen
Journal:  J Mol Biol       Date:  1992-08-20       Impact factor: 5.469

7.  Two mutations in the tetracycline repressor change the inducer anhydrotetracycline to a corepressor.

Authors:  Annette Kamionka; Joanna Bogdanska-Urbaniak; Oliver Scholz; Wolfgang Hillen
Journal:  Nucleic Acids Res       Date:  2004-02-04       Impact factor: 16.971

Review 8.  Mechanisms underlying expression of Tn10 encoded tetracycline resistance.

Authors:  W Hillen; C Berens
Journal:  Annu Rev Microbiol       Date:  1994       Impact factor: 15.500

9.  Genes required for mycobacterial growth defined by high density mutagenesis.

Authors:  Christopher M Sassetti; Dana H Boyd; Eric J Rubin
Journal:  Mol Microbiol       Date:  2003-04       Impact factor: 3.501

10.  Tetracycline-inducible gene regulation in mycobacteria.

Authors:  Marian C J Blokpoel; Helen N Murphy; Ronan O'Toole; Siouxsie Wiles; Ellen S C Runn; Graham R Stewart; Douglas B Young; Brian D Robertson
Journal:  Nucleic Acids Res       Date:  2005-02-01       Impact factor: 16.971

View more
  21 in total

1.  Free Trehalose Accumulation in Dormant Mycobacterium smegmatis Cells and Its Breakdown in Early Resuscitation Phase.

Authors:  Margarita O Shleeva; Kseniya A Trutneva; Galina R Demina; Alexander I Zinin; Galina M Sorokoumova; Polina K Laptinskaya; Ekaterina S Shumkova; Arseny S Kaprelyants
Journal:  Front Microbiol       Date:  2017-03-30       Impact factor: 5.640

2.  Distinct Mechanism Evolved for Mycobacterial RNA Polymerase and Topoisomerase I Protein-Protein Interaction.

Authors:  Srikanth Banda; Nan Cao; Yuk-Ching Tse-Dinh
Journal:  J Mol Biol       Date:  2017-08-24       Impact factor: 5.469

3.  Regulated Expression Systems for Mycobacteria and Their Applications.

Authors:  Dirk Schnappinger; Sabine Ehrt
Journal:  Microbiol Spectr       Date:  2014

4.  Engineering of bacteria for the visualization of targeted delivery of a cytolytic anticancer agent.

Authors:  Sheng-Nan Jiang; Seung-Hwan Park; Hee Jung Lee; Jin Hai Zheng; Hyung-Seok Kim; Hee-Seung Bom; Yeongjin Hong; Michael Szardenings; Myung Geun Shin; Sun-Chang Kim; Vasilis Ntziachristos; Hyon E Choy; Jung-Joon Min
Journal:  Mol Ther       Date:  2013-08-07       Impact factor: 11.454

5.  Small-Molecule Inhibitors Targeting Topoisomerase I as Novel Antituberculosis Agents.

Authors:  Shayna Sandhaus; Thirunavukkarasu Annamalai; Greg Welmaker; Richard A Houghten; Carlos Paz; Pamela K Garcia; Angelo Andres; Gagandeep Narula; Carolina Rodrigues Felix; Sandra Geden; Mandy Netherton; Rashmi Gupta; Kyle H Rohde; Marc A Giulianotti; Yuk-Ching Tse-Dinh
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

6.  Cell division site placement and asymmetric growth in mycobacteria.

Authors:  Graham Joyce; Kerstin J Williams; Matthew Robb; Elke Noens; Barbara Tizzano; Vahid Shahrezaei; Brian D Robertson
Journal:  PLoS One       Date:  2012-09-10       Impact factor: 3.240

7.  Simultaneous analysis of multiple Mycobacterium tuberculosis knockdown mutants in vitro and in vivo.

Authors:  Antje Blumenthal; Carolina Trujillo; Sabine Ehrt; Dirk Schnappinger
Journal:  PLoS One       Date:  2010-12-22       Impact factor: 3.240

8.  Characterization of the mycobacterial acyl-CoA carboxylase holo complexes reveals their functional expansion into amino acid catabolism.

Authors:  Matthias T Ehebauer; Michael Zimmermann; Arjen J Jakobi; Elke E Noens; Daniel Laubitz; Bogdan Cichocki; Hedia Marrakchi; Marie-Antoinette Lanéelle; Mamadou Daffé; Carsten Sachse; Andrzej Dziembowski; Uwe Sauer; Matthias Wilmanns
Journal:  PLoS Pathog       Date:  2015-02-19       Impact factor: 6.823

9.  The engineered Salmonella typhimurium inhibits tumorigenesis in advanced glioma.

Authors:  Jian-Qiang Chen; Yue-Fu Zhan; Wei Wang; Sheng-Nan Jiang; Xiang-Ying Li
Journal:  Onco Targets Ther       Date:  2015-09-15       Impact factor: 4.147

10.  Structural insights into the functional divergence of WhiB-like proteins in Mycobacterium tuberculosis.

Authors:  Tao Wan; Magdaléna Horová; Daisy Guiza Beltran; Shanren Li; Huey-Xian Wong; Li-Mei Zhang
Journal:  Mol Cell       Date:  2021-06-24       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.